Title: Supplemental bifid triple viable capsule treatment improves inflammatory response and
T cell frequency in ulcerative colitis patients
Version: 0 Date: 03 Feb 2021
Reviewer's report:
Overall the manuscript addresses an important topic and investigates new options to cure
ulcerative colitis.
There are major concerns that need to be addressed to re-write the manuscript for consideration.
Therefore, I am not able to accept this manuscript.
The introduction needs that evidence for the use of somatostatin are detailed.
Efficacy of treatment should be addressed with colonoscopy to answer whether the patient is in
endoscopic remission or not. Mucosal healing is the treatment target for UC.
English is too poor.
Title: Supplemental bifid triple viable capsule treatment improves inflammatory response and
T cell frequency in ulcerative colitis patients
Version: 0 Date: 03 Feb 2021
Reviewer's report:
Overall the manuscript addresses an important topic and investigates new options to cure
ulcerative colitis.
There are major concerns that need to be addressed to re-write the manuscript for consideration.
Therefore, I am not able to accept this manuscript.
The introduction needs that evidence for the use of somatostatin are detailed.
Efficacy of treatment should be addressed with colonoscopy to answer whether the patient is in
endoscopic remission or not. Mucosal healing is the treatment target for UC.
English is too poor.
Please review this paper.
user
Title: Supplemental bifid triple viable capsule treatment improves inflammatory response and
T cell frequency in ulcerative colitis patients
Version: 0 Date: 03 Feb 2021
Reviewer's report:
Overall the manuscript addresses an important topic and investigates new options to cure
ulcerative colitis.
There are major concerns that need to be addressed to re-write the manuscript for consideration.
Therefore, I am not able to accept this manuscript.
The introduction needs that evidence for the use of somatostatin are detailed.
Efficacy of treatment should be addressed with colonoscopy to answer whether the patient is in
endoscopic remission or not. Mucosal healing is the treatment target for UC.
English is too poor.
assistant